Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.86 HKD | +1.03% | -4.06% | +2.69% |
Apr. 15 | Ocumension Therapeutics Completes Phase III Trials for Postoperative Inflammation Drug | MT |
Apr. 15 | Ocumension Therapeutics Announces Phase III Clinical Trial of OT-502 in China | CI |